Based on these findings, it was surmised that CARD9 deletion affords protection against HFD-induced inflammation, insulin resistance, metabolic abnormalities, and T2DM either by suppressing NF-κB and MAPKs signaling modules and/or improving insulin action and increased energy metabolism. This evidence concerns the gene INS and type 2 diabetes mellitus.